Ana Alcaraz‐Serna

1.2k citations
5 papers · 106 indexed · h-index 4
Topics
Immunotherapy and Immune Responses (2 papers)SARS-CoV-2 and COVID-19 Research (1 paper)Cancer-related Molecular Pathways (1 paper)
Partner nations
SpainSwitzerland

In The Last Decade

Ana Alcaraz‐Serna

5 papers receiving 104 citations

Peers

Ana Alcaraz‐Serna
Comparison fields: 5 of 40
  • Molecular Biology 45
  • Immunology 41
  • Oncology 30
  • Cardiology and Cardiovascular Medicine 18
  • Hematology 12
Replace Rana H. Besada with:
Rana H. Besada United States
Fabiola Bene United Kingdom
Gabriella Widmer Switzerland
I. Meuthen Germany
Rachel B. Blaustein United States
Sayaka Aoyagi Japan
Viktoria Eichwald Germany
Virginie Persoons France
Esther Hian Li Chan Singapore
Ana Alcaraz‐Serna relative to Rana H. Besada United States Rana H. Besada's profile →
Citations per field
00.5×
Rana H. Besada · 1×
Citations per year

Countries citing papers authored by Ana Alcaraz‐Serna

Since Specialization
Citations

This map shows the geographic impact of Ana Alcaraz‐Serna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Alcaraz‐Serna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Alcaraz‐Serna more than expected).

Fields of papers citing papers by Ana Alcaraz‐Serna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Alcaraz‐Serna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Alcaraz‐Serna. The network helps show where Ana Alcaraz‐Serna may publish in the future.

Co-authorship network of co-authors of Ana Alcaraz‐Serna

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Alcaraz‐Serna. A scholar is included among the top collaborators of Ana Alcaraz‐Serna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Alcaraz‐Serna. Ana Alcaraz‐Serna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1 2
2 15
3 8
4 42
5 39

About Ana Alcaraz‐Serna

Ana Alcaraz‐Serna is a scholar working on Immunology and Allergy, Immunology and Genetics, having authored 5 papers that have together received 106 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Immunology (41 citations), Oncology (30 citations) and Hematology (12 citations). Ana Alcaraz‐Serna has collaborated with scholars based in Spain and Switzerland. Frequent co-authors include Francisco Sánchez‐Madrid, Arántzazu Alfranca, Santiago Sánchez‐Alonso, Cecilia Muñoz‐Calleja, Carlos Cuesta‐Mateos, Beatriz Somovilla-Crespo, Manuel J. Gómez, Irene Fernández‐Delgado, Ana Dopazo and Fátima Sánchez‐Cabo. Their work appears in journals such as Scientific Reports, Science Advances and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026